Redeye: Xspray Pharm (Q3 update) - Two PDUFA dates in 2026
7 november, 08:52
7 november, 08:52
Redeye updates on Xspray following its Q3 report, which featured undramatic financials but offered additional insight into the ongoing regulatory processes. Important newsflow is expected in Q4 regarding both XS003 and Dasynoc, and Xspray is likely heading toward two PDUFA dates by the summer of 2026.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
7 november, 08:52
Redeye updates on Xspray following its Q3 report, which featured undramatic financials but offered additional insight into the ongoing regulatory processes. Important newsflow is expected in Q4 regarding both XS003 and Dasynoc, and Xspray is likely heading toward two PDUFA dates by the summer of 2026.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
Analyser
Aktieråd
SBB
Inflationen
Analyser
Aktieråd
SBB
Inflationen
1 DAG %
Senast
Addtech
Idag, 13:15
Stockholmsbörsen mot ny rekordnivå
OMX Stockholm 30
1 DAG %
Senast
2 842,41